Insider · CIK 0002037898
John Ackerman
Files at GRDN (Guardian Pharmacy Services, Inc.). First filing May 29, 2025, latest Mar 24, 2026.
In brief
John Ackerman files SEC Form 4 as director at GRDN (Guardian Pharmacy Services, Inc.). Since May 29, 2025, John Ackerman has reported 0 open-market buys worth $0 and 2 open-market sells worth $59M, the latest filed on Mar 24, 2026.
A track record needs three past buys with six months of prices behind them; John Ackerman has 0, so none is measured yet.
The newest scored trade: sold $33M of GRDN on Mar 20, 2026, filed Mar 24, 2026, scored 75 (notable). In the last 12 months: 0 buys worth $0 and 1 sell worth $33M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GRDN: Guardian Pharmacy Services, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 75Notable | Guardian Pharmacy Services, Inc. | $33M 1,103,364 shares | -59% | +81% from low0% from high | |
| 75Notable | Guardian Pharmacy Services, Inc. | $26M 1,285,579 shares | -91% | +38% from low-17% from high |
Transactions
Every row this insider has filed, 22 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 27, 2026 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class A Common Stockindirect: By Pharmacy Investors, LLC | +1,413,939 | - | - | 3,863,806 | 15 d ago |
| Sep 27, 2026 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class A Common Stockindirect: By Cardinal Equity Fund, L.P. | +471,057 | - | - | 1,287,237 | 15 d ago |
| Sep 27, 2026 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class B Common Stockderivativeindirect: By Pharmacy Investors, LLC | -1,413,939 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class B Common Stockderivativeindirect: By Cardinal Equity Fund, L.P. | -471,057 | - | - | 0 | 15 d ago |
| Mar 28, 2026 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class A Common Stockindirect: By Pharmacy Investors, LLC | +1,413,939 | - | - | 2,449,867 | Mar 31, 2026 |
| Mar 28, 2026 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class A Common Stockindirect: By Cardinal Equity Fund, L.P. | +471,057 | - | - | 816,180 | Mar 31, 2026 |
| Mar 28, 2026 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class B Common Stockderivativeindirect: By Pharmacy Investors, LLC | -1,413,939 | - | - | 1,413,939 | Mar 31, 2026 |
| Mar 28, 2026 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class B Common Stockderivativeindirect: By Cardinal Equity Fund, L.P. | -471,057 | - | - | 471,057 | Mar 31, 2026 |
| Mar 20, 2026 | GRDN Guardian Pharmacy Services, Inc. | SOpen-market sale Class A Common Stockindirect: By Pharmacy Investors, LLC | -827,636 | $29.68 | $25M | 1,035,928 | Mar 24, 2026 |
| Mar 20, 2026 | GRDN Guardian Pharmacy Services, Inc. | SOpen-market sale Class A Common Stockindirect: By Cardinal Equity Fund, L.P. | -275,728 | $29.68 | $8.2M | 345,123 | Mar 24, 2026 |
| Sep 27, 2025 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class A Common Stockindirect: By Pharmacy Investors, LLC | +1,413,940 | - | - | 1,863,564 | Sep 30, 2025 |
| Sep 27, 2025 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class A Common Stockindirect: By Cardinal Equity Fund, L.P. | +471,057 | - | - | 620,851 | Sep 30, 2025 |
| Sep 27, 2025 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class B Common Stockderivativeindirect: By Pharmacy Investors, LLC | -1,413,940 | - | - | 2,827,878 | Sep 30, 2025 |
| Sep 27, 2025 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class B Common Stockderivativeindirect: By Cardinal Equity Fund, L.P. | -471,057 | - | - | 942,114 | Sep 30, 2025 |
| May 27, 2025 | GRDN Guardian Pharmacy Services, Inc. | SOpen-market sale Class A Common Stockindirect: By Pharmacy Investors, LLC | -813,318 | $20.16 | $16M | 600,622 | May 29, 2025 |
| May 27, 2025 | GRDN Guardian Pharmacy Services, Inc. | SOpen-market sale Class A Common Stockindirect: By Cardinal Equity Fund, L.P. | -270,958 | $20.16 | $5.5M | 200,099 | May 29, 2025 |
| May 28, 2025 | GRDN Guardian Pharmacy Services, Inc. | SOpen-market sale Class A Common Stockindirect: By Pharmacy Investors, LLC | -150,998 | $20.16 | $3.0M | 449,624 | May 29, 2025 |
| May 28, 2025 | GRDN Guardian Pharmacy Services, Inc. | SOpen-market sale Class A Common Stockindirect: By Cardinal Equity Fund, L.P. | -50,305 | $20.16 | $1.0M | 149,794 | May 29, 2025 |
| Mar 28, 2025 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class A Common Stockindirect: By Pharmacy Investors, LLC | +1,413,940 | - | - | 1,413,940 | Apr 1, 2025 |
| Mar 28, 2025 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class A Common Stockindirect: By Cardinal Equity Fund, L.P. | +471,057 | - | - | 471,057 | Apr 1, 2025 |
| Mar 28, 2025 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class B Common Stockderivativeindirect: By Pharmacy Investors, LLC | -1,413,940 | - | - | 4,241,818 | Apr 1, 2025 |
| Mar 28, 2025 | GRDN Guardian Pharmacy Services, Inc. | MOption exercise Class B Common Stockderivativeindirect: By Cardinal Equity Fund, L.P. | -471,057 | - | - | 1,413,171 | Apr 1, 2025 |
Questions about John Ackerman
Answered from the filings on this page, as of the latest one.
Is John Ackerman buying or selling?
In the last 12 months John Ackerman reported 0 open-market buys worth $0 and 1 open-market sell worth $33M on SEC Form 4; the latest was sold $33M of GRDN on Mar 20, 2026. Grants, option exercises and tax withholding are not counted.
How did John Ackerman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Ackerman has 0.
Where does John Ackerman file Form 4?
John Ackerman has filed Form 4 at GRDN (Guardian Pharmacy Services, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.